4//SEC Filing
Darvish Nissim 4
Accession 0001178913-22-001026
CIK 0001534248other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:08 PM ET
Size
9.8 KB
Accession
0001178913-22-001026
Insider Transaction Report
Form 4
Darvish Nissim
Director
Transactions
- Award
Option to Purchase American Depositary Shares
2022-03-07+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying) - Award
Option to Purchase American Depositary Shares
2021-04-19+11,884→ 11,884 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying)
Holdings
- 10,123
Option to Purchase American Depositary Shares
Exercise: $0.80Exp: 2026-10-27→ American Depositary Shares (10,123 underlying)
Footnotes (5)
- [F1]These options vest and become exercisable in their entirety on March 16, 2023.
- [F2]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
- [F5]The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001793602
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:08 PM ET
- Size
- 9.8 KB